Connective tissue growth factor and cardiac diastolic dysfunction: Human data from the Taiwan Diastolic Heart Failure Registry and molecular basis by cellular and animal models

Cho Kai Wu, Yi Chih Wang, Jen Kuang Lee, Sheng Nan Chang, Mao Yuan Su, Huei Ming Yeh, Ming Jai Su, Jin Jer Chen, Fu Tien Chiang, Juey Jen Hwang, Jiunn Lee Lin, Chia Ti Tsai

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Aims: Connective tissue growth factor (CTGF) is an emerging marker for tissue fibrosis. We investigated the association between CTGF and cardiac diastolic function using cellular and animal models and clinical human data. Methods A total of 125 patients with a diagnosis of diastolic heart failure (DHF) were recruited from 1283 patients of the and results: Taiwan Diastolic Heart Failure Registry. The severity of DHF was determined by tissue Doppler imaging (E/e'). Cardiac magnetic resonance imaging (CMRI) was used to evaluate myocardial fibrosis in some of the patients (n = 25). Stretch of cardiomyocytes on a flexible membrane base serves as a cellular phenotype of cardiac diastolic dysfunction (DD). A canine model of DD was induced by aortic banding. A significant correlation was found between plasma CTGF and E/e' in DHF patients. The severity of cardiac fibrosis evaluated by CMRI also correlated with CTGF. In the cell model, stretch increased secretion of CTGF from cardiomyocytes. In the canine model, myocardial tissue CTGF expression and fibrosis significantly increased after 2 weeks of aortic banding. Notably, the expression of CTGF paralleled the severity of LV DD (r = 0.40, P < 0.001 for E/e') and haemodynamic changes (r = 0.80, P < 0.001). After adjusting for confounding factors, CTGF levels still correlated with diastolic parameters in both human and canine models (human plasma CTGF, P < 0.001; canine tissue CTGF, P = 0.04). Conclusion: Plasma CTGF level correlated with the severity of DD and tissue fibrosis in DHF patients. The mechanism may be through myocardial stretch. Our study indicated that CTGF may serve as an early marker for DHF.

Original languageEnglish
Pages (from-to)163-172
Number of pages10
JournalEuropean Journal of Heart Failure
Volume16
Issue number2
DOIs
Publication statusPublished - Jan 1 2014
Externally publishedYes

Fingerprint

Diastolic Heart Failure
Connective Tissue Growth Factor
Taiwan
Registries
Animal Models
Fibrosis
Canidae
Cardiac Myocytes
Magnetic Resonance Imaging

Keywords

  • Canine model
  • Connective tissue growth factor
  • Diastolic heart failure
  • Fibrosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Connective tissue growth factor and cardiac diastolic dysfunction : Human data from the Taiwan Diastolic Heart Failure Registry and molecular basis by cellular and animal models. / Wu, Cho Kai; Wang, Yi Chih; Lee, Jen Kuang; Chang, Sheng Nan; Su, Mao Yuan; Yeh, Huei Ming; Su, Ming Jai; Chen, Jin Jer; Chiang, Fu Tien; Hwang, Juey Jen; Lin, Jiunn Lee; Tsai, Chia Ti.

In: European Journal of Heart Failure, Vol. 16, No. 2, 01.01.2014, p. 163-172.

Research output: Contribution to journalArticle

Wu, Cho Kai ; Wang, Yi Chih ; Lee, Jen Kuang ; Chang, Sheng Nan ; Su, Mao Yuan ; Yeh, Huei Ming ; Su, Ming Jai ; Chen, Jin Jer ; Chiang, Fu Tien ; Hwang, Juey Jen ; Lin, Jiunn Lee ; Tsai, Chia Ti. / Connective tissue growth factor and cardiac diastolic dysfunction : Human data from the Taiwan Diastolic Heart Failure Registry and molecular basis by cellular and animal models. In: European Journal of Heart Failure. 2014 ; Vol. 16, No. 2. pp. 163-172.
@article{ed7a852e6c94489aaa998a8a591f1e44,
title = "Connective tissue growth factor and cardiac diastolic dysfunction: Human data from the Taiwan Diastolic Heart Failure Registry and molecular basis by cellular and animal models",
abstract = "Aims: Connective tissue growth factor (CTGF) is an emerging marker for tissue fibrosis. We investigated the association between CTGF and cardiac diastolic function using cellular and animal models and clinical human data. Methods A total of 125 patients with a diagnosis of diastolic heart failure (DHF) were recruited from 1283 patients of the and results: Taiwan Diastolic Heart Failure Registry. The severity of DHF was determined by tissue Doppler imaging (E/e'). Cardiac magnetic resonance imaging (CMRI) was used to evaluate myocardial fibrosis in some of the patients (n = 25). Stretch of cardiomyocytes on a flexible membrane base serves as a cellular phenotype of cardiac diastolic dysfunction (DD). A canine model of DD was induced by aortic banding. A significant correlation was found between plasma CTGF and E/e' in DHF patients. The severity of cardiac fibrosis evaluated by CMRI also correlated with CTGF. In the cell model, stretch increased secretion of CTGF from cardiomyocytes. In the canine model, myocardial tissue CTGF expression and fibrosis significantly increased after 2 weeks of aortic banding. Notably, the expression of CTGF paralleled the severity of LV DD (r = 0.40, P < 0.001 for E/e') and haemodynamic changes (r = 0.80, P < 0.001). After adjusting for confounding factors, CTGF levels still correlated with diastolic parameters in both human and canine models (human plasma CTGF, P < 0.001; canine tissue CTGF, P = 0.04). Conclusion: Plasma CTGF level correlated with the severity of DD and tissue fibrosis in DHF patients. The mechanism may be through myocardial stretch. Our study indicated that CTGF may serve as an early marker for DHF.",
keywords = "Canine model, Connective tissue growth factor, Diastolic heart failure, Fibrosis, Canine model, Connective tissue growth factor, Diastolic heart failure, Fibrosis",
author = "Wu, {Cho Kai} and Wang, {Yi Chih} and Lee, {Jen Kuang} and Chang, {Sheng Nan} and Su, {Mao Yuan} and Yeh, {Huei Ming} and Su, {Ming Jai} and Chen, {Jin Jer} and Chiang, {Fu Tien} and Hwang, {Juey Jen} and Lin, {Jiunn Lee} and Tsai, {Chia Ti}",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/ejhf.33",
language = "English",
volume = "16",
pages = "163--172",
journal = "European Journal of Heart Failure",
issn = "1388-9842",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Connective tissue growth factor and cardiac diastolic dysfunction

T2 - Human data from the Taiwan Diastolic Heart Failure Registry and molecular basis by cellular and animal models

AU - Wu, Cho Kai

AU - Wang, Yi Chih

AU - Lee, Jen Kuang

AU - Chang, Sheng Nan

AU - Su, Mao Yuan

AU - Yeh, Huei Ming

AU - Su, Ming Jai

AU - Chen, Jin Jer

AU - Chiang, Fu Tien

AU - Hwang, Juey Jen

AU - Lin, Jiunn Lee

AU - Tsai, Chia Ti

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Aims: Connective tissue growth factor (CTGF) is an emerging marker for tissue fibrosis. We investigated the association between CTGF and cardiac diastolic function using cellular and animal models and clinical human data. Methods A total of 125 patients with a diagnosis of diastolic heart failure (DHF) were recruited from 1283 patients of the and results: Taiwan Diastolic Heart Failure Registry. The severity of DHF was determined by tissue Doppler imaging (E/e'). Cardiac magnetic resonance imaging (CMRI) was used to evaluate myocardial fibrosis in some of the patients (n = 25). Stretch of cardiomyocytes on a flexible membrane base serves as a cellular phenotype of cardiac diastolic dysfunction (DD). A canine model of DD was induced by aortic banding. A significant correlation was found between plasma CTGF and E/e' in DHF patients. The severity of cardiac fibrosis evaluated by CMRI also correlated with CTGF. In the cell model, stretch increased secretion of CTGF from cardiomyocytes. In the canine model, myocardial tissue CTGF expression and fibrosis significantly increased after 2 weeks of aortic banding. Notably, the expression of CTGF paralleled the severity of LV DD (r = 0.40, P < 0.001 for E/e') and haemodynamic changes (r = 0.80, P < 0.001). After adjusting for confounding factors, CTGF levels still correlated with diastolic parameters in both human and canine models (human plasma CTGF, P < 0.001; canine tissue CTGF, P = 0.04). Conclusion: Plasma CTGF level correlated with the severity of DD and tissue fibrosis in DHF patients. The mechanism may be through myocardial stretch. Our study indicated that CTGF may serve as an early marker for DHF.

AB - Aims: Connective tissue growth factor (CTGF) is an emerging marker for tissue fibrosis. We investigated the association between CTGF and cardiac diastolic function using cellular and animal models and clinical human data. Methods A total of 125 patients with a diagnosis of diastolic heart failure (DHF) were recruited from 1283 patients of the and results: Taiwan Diastolic Heart Failure Registry. The severity of DHF was determined by tissue Doppler imaging (E/e'). Cardiac magnetic resonance imaging (CMRI) was used to evaluate myocardial fibrosis in some of the patients (n = 25). Stretch of cardiomyocytes on a flexible membrane base serves as a cellular phenotype of cardiac diastolic dysfunction (DD). A canine model of DD was induced by aortic banding. A significant correlation was found between plasma CTGF and E/e' in DHF patients. The severity of cardiac fibrosis evaluated by CMRI also correlated with CTGF. In the cell model, stretch increased secretion of CTGF from cardiomyocytes. In the canine model, myocardial tissue CTGF expression and fibrosis significantly increased after 2 weeks of aortic banding. Notably, the expression of CTGF paralleled the severity of LV DD (r = 0.40, P < 0.001 for E/e') and haemodynamic changes (r = 0.80, P < 0.001). After adjusting for confounding factors, CTGF levels still correlated with diastolic parameters in both human and canine models (human plasma CTGF, P < 0.001; canine tissue CTGF, P = 0.04). Conclusion: Plasma CTGF level correlated with the severity of DD and tissue fibrosis in DHF patients. The mechanism may be through myocardial stretch. Our study indicated that CTGF may serve as an early marker for DHF.

KW - Canine model

KW - Connective tissue growth factor

KW - Diastolic heart failure

KW - Fibrosis

KW - Canine model

KW - Connective tissue growth factor

KW - Diastolic heart failure

KW - Fibrosis

UR - http://www.scopus.com/inward/record.url?scp=84896959006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896959006&partnerID=8YFLogxK

U2 - 10.1002/ejhf.33

DO - 10.1002/ejhf.33

M3 - Article

C2 - 24464932

AN - SCOPUS:84896959006

VL - 16

SP - 163

EP - 172

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

SN - 1388-9842

IS - 2

ER -